Drug recall · April 22, 2026
Cinacalcet Hydrochloride Tablets recall
Why: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02
- Lots / codes
Lot, expiry: Lot 4PB0526, 4PB0527, 4PB0528, exp September-2026; Lot 5PB0173, exp January-2027
- Quantity
- 113,336 bottles
- Company
- Cipla USA, Inc., Warren, NJ
- Distribution
- Nationwide in the USA
- Initiated
- March 16, 2026 · Voluntary: Firm initiated
- Classified
- April 10, 2026
- Reported
- April 22, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cinacalcet
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.